SCHEMBL20590809

SCHEMBL20590809

CCOC(=O)N=S(C)(=O)c1cccc(C(=O)OC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.47
LOX P28300 1/20 0.46
TSHR P16473 1/20 0.45
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
KMT2A Q03164 1/20 0.44
TCF4 P15884 2/20 0.44
CTNNB1 P35222 2/20 0.44
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
LOXL2 Q9Y4K0 1/20 0.43
MAPT P10636 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
CYP4F2 P78329 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1706529 0.82 POLB (0.46) POLBKMT2ARAB9A
SCHEMBL14495875 0.80 POLB (0.50) POLBTSHRKDM4EALDH1A1KMT2A
SCHEMBL2464413 0.80 POLB (0.50) POLBTSHRKDM4EALDH1A1KMT2A
SCHEMBL17501270 0.80 POLB (0.44) POLBKDM4EALDH1A1KMT2AMAPT
SCHEMBL12390716 0.80 POLB (0.50) POLBTSHRKDM4EALDH1A1KMT2A
SCHEMBL19277128 0.79 POLB (0.43) POLBTSHRALDH1A1KMT2ACA2
SCHEMBL16094564 0.78 POLB (0.48) POLBLOXKDM4EALDH1A1KMT2A
SCHEMBL10231885 0.78 POLB (0.42) POLBALDH1A1KMT2ACA2MAPT
SCHEMBL1707322 0.78 POLB (0.42) POLBCA2MAPTCYP3A4CYP2D6
SCHEMBL23224423 0.76 LOX (0.54) POLBLOXTSHRKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210040062-A1 AZOLE-SUBSTITUTED PYRIDINE COMPOUND TAISHO PHARMACEUTICAL CO., LTD. (JP) 2021-02-11 US disclosed
EP-3418276-A1 AZOLE-SUBSTITUTED PYRIDINE COMPOUND Taisho Pharmaceutical Co., Ltd. (JP) 2018-12-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210040062-A1 AZOLE-SUBSTITUTED PYRIDINE COMPOUND CYP2F1, CYP21A2, CYP11B1 POLB 4110/4885LOX 190/4885TSHR 2861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.